NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy Cell Rep Med
Analysis of the interplay between MeCP2 and histone H1 during in vitro differentiation of human ReNCell neural progenitor cells EPIGENETICS-US
Antithrombotic and prohemorrhagic actions of different concentrations of apixaban in patients exposed to single and dual antiplatelet regimens SCI REP-UK
Serum DNA methylome of the colorectal cancer serrated pathway enables non-invasive detection Mol Oncol
MAF amplification licenses ERα through epigenetic remodelling to drive breast cancer metastasis Nat Cell Biol
CompCorona: A web application for comparative transcriptome analyses of coronaviruses reveals SARS-CoV-2-specific host response Turk J Biol
Exportin 1-mediated nuclear/cytoplasmic trafficking controls drug sensitivity of classical Hodgkin lymphoma Mol Oncol
The PENGUIN approach to reconstruct protein interactions at enhancer-promoter regions and its application to prostate cancer Nat Commun
Venetoclax with hypomethylating agents might lead to eradication of measurable residual disease (MRD) persisting after intensive chemotherapy in acute myeloid leukemia (AML) patients with mutated NPM1 and rearranged CBF LEUKEMIA RES